MedPath

Intraoperative Protective Mechanical Ventilation in Patients Requiring Emergency Abdominal Surgery

Not Applicable
Completed
Conditions
Postoperative Morbidity
Mechanical Ventilation
Emergency Abdominal Surgery
General Anesthesia
Interventions
Other: Driving-pressure-guided group
Other: Low PEEP
Registration Number
NCT03987789
Lead Sponsor
University Hospital, Clermont-Ferrand
Brief Summary

The aim of this study is to compare the effects of a strategy aimed at increasing alveolar recruitment (high PEEP levels adjusted according to driving pressure and recruitment maneuvers) with that of a strategy aimed at minimizing alveolar distension (low PEEP level without recruitment maneuver) on postoperative respiratory failure and mortality in patients receiving low VT ventilation during emergency abdominal surgery.

Detailed Description

Emergency abdominal surgery is associated with a high risk of morbidity and mortality. Postoperative pulmonary complications (PPCs) are the second most common surgical complication and adversely influence surgical morbidity. Postoperative respiratory failure (PRF) is one of the most serious pulmonary complication.

Two hypotheses can be forward by the literature. First, a low VT lung protective ventilation in combination with a strategy aimed at minimizing alveolar distension by using low PEEP level (and without recruitment maneuver) could improve postoperative outcome while reducing the risk of hemodynamic alterations or, second, could increase the risk of PRF compared with a strategy aimed at increasing alveolar recruitment using higher PEEP level adjusted according to driving pressure in combination with recruitment maneuvers in adult patients undergoing emergency abdominal surgery. Given the uncertainties, and in order to determine the impact of lung protective ventilation strategies on clinical outcomes of high-risk surgical patients, a randomized trial is needed.

Our primary hypothesis is that, during low VT ventilation, a strategy aimed at increasing alveolar recruitment by using high PEEP levels adjusted according to driving pressure in combination with recruitment maneuvers could be more effective at reducing PRF and mortality after emergency abdominal surgery than a strategy aimed at minimizing alveolar distension by using lower PEEP without recruitment maneuver.

Given the number of patients for whom the question applies, the prevalence and the burden of PPCs, the study can have significant clinical importance and public health implications.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
707
Inclusion Criteria
  • Adult (≥18 years)
  • Patients requiring emergency (defined by the need to proceed to surgery within a few hours after diagnosis)
  • Laparoscopic or non-laparoscopic abdominal surgery under general anesthesia and with an expected duration of at least two hours
Exclusion Criteria
  • Patients already receiving mechanical ventilation for more than 12 hours before enrollment
  • Intracranial hypertension
  • Chronic respiratory disease requiring oxygen therapy or mechanical ventilation at home
  • Undrained pneumothorax or subcutaneous emphysema
  • Patients for which death is deemed imminent and inevitable or patients with an underlying disease process with a life expectancy of less than 3 month
  • Body mass index (BMI) >40 kg/m2
  • Pregnant or breastfeeding women
  • Patients already enrolled in the IMPROVE-2 trial
  • Participation in a confounding trial with mortality or PRF as the main endpoint
  • Patient's or relative's refusal to participate
  • Guardianship or trusteeship patient
  • No affiliation to the Social Security system

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Driving-pressure-guided groupDriving-pressure-guided groupPatients will receive PEEP levels individually set at the highest possible value (up to 15 cmH2O) providing a driving pressure (airway plateau pressure minus PEEP) lower than 13 cmH2O, in addition to recruitment maneuvers
Low PEEP groupLow PEEPPatients will receive a PEEP level ≤5 cmH2O without recruitment maneuvers
Primary Outcome Measures
NameTimeMethod
Postoperative respiratory failureHospital discharge - Up to day 30

Composite criteria :

1. - Failure to wean from the ventilator after surgery (Yes or No)

2. - Requiring unplanned reintubation (Yes or No)

3. - Curative non-invasive ventilation once extubated postoperatively (Yes or No)

4. - Death (all cause of mortality) (Yes or No)

If at least one of these 4 criteria is answered yes, the composite criterion (i.e. the primary outcome) will be answered yes

Secondary Outcome Measures
NameTimeMethod
Median ephedrine doses during surgeryDay 1

µg/kg/min

SOFADay 7

Sequential-related Organ Failure Assessment

Ventilator-free daysDay 30

The number of days alive and with unassisted breathing

Time to successful tracheal extubation48 hours

Absence of ventilatory support during the first 48 hours after extubation

Median norepinephrine doses during surgeryDay 1

µg/kg/min

Duration of ICU stayUp to day 90

Duration of ICU stay

Postoperative pulmonary complicationsDay 30

Hypoxemia, pneumonia? development of acute respiratory distress syndrome (ARDS)

Postoperative extra-pulmonary complicationsDay 30

sepsis and septic shock, renal dysfunction

Intensive care unit (ICU)-free daysDay 30

Intensive care unit (ICU)-free days

Duration of hospital stayUp to day 90

Duration of hospital stay

All-cause mortalityDay 90

All-cause mortality

Hemodynamic instabilityUp to day 30

Hemodynamic instability ventilatory-related defined as a drop of arterial systolic pressure below 80 mmHg for more than 5 minutes not responding to treatment

Duration of invasive mechanical ventilationUp to Day 30

Duration of invasive mechanical ventilation from randomization to first tracheal extubation

Total duration of mechanical ventilationUp to Day 30

Total duration of mechanical ventilation (additive, for all épisodes)

Total volume of intraoperative fluidsDay 1

Total volume of intraoperative fluids (crystalloids and colloids)

Median phenylephrine doses during surgeryDay 1

µg/kg/min

Time to deathUp to 90 days

Time to death (Days)

PneumothoraxUp to day 30

Pneumothorax ventilatory-related

Trial Locations

Locations (6)

Institut Paoli Calmette

🇫🇷

Marseille, France

Assistance Publique-Hôpitaux de Paris

🇫🇷

Paris, France

University hospital

🇫🇷

Toulouse, France

Hospital

🇫🇷

Valenciennes, France

Assistance Publique-Hôpitaux de Marseille

🇫🇷

Marseille, France

University Hospital

🇫🇷

Nantes, France

© Copyright 2025. All Rights Reserved by MedPath